Back to Search
Start Over
FDA approves two sickle cell therapies, including the first CRISPR medicine
- Source :
- The Washington Post. December 8, 2023
- Publication Year :
- 2023
-
Abstract
- Byline: Carolyn Y. Johnson In a major advance, the Food and Drug Administration on Friday approved two gene therapies that target sickle cell disease, one of which is the first [...]
- Subjects :
- bluebird bio, Inc. -- Product development
Vertex Pharmaceuticals Inc. -- Product development
Sickle cell anemia -- Care and treatment
Biotechnology industry -- Product development
Gene therapy -- Licensing, certification and accreditation
Pharmaceutical industry
General interest
News, opinion and commentary
Casgevy (Medication) -- Licensing, certification and accreditation
Lyfgenia (Medication) -- Licensing, certification and accreditation
Subjects
Details
- Language :
- English
- ISSN :
- 01908286
- Database :
- Gale General OneFile
- Journal :
- The Washington Post
- Publication Type :
- News
- Accession number :
- edsgcl.775709975